In Brief: Fresenius USA
This article was originally published in The Gray Sheet
Executive SummaryFresenius USA: Company selects Salomon Brothers Inc. to aid in the assessment and negotiation of economic terms on which FUSA would participate in combining Fresenius AG, FUSA and W.R. Grace's National Medical Care unit into Fresenius Medical Care. Under terms of the definitive agreement, announced Feb. 4, Fresenius AG would purchase 55% of NMC for $2.3 mil. in cash. FUSA is approximately 70% owned by Germany-based Fresenius AG...
You may also be interested in...
The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.
The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings.
Hikma and Civica Rx have announced the launch of a first wave of eight essential injectable medicines, including heparin, as part of a deal struck between the two firms earlier this year.